Related Experiment Videos

Response of L-1210 tumor in mice toward treatment with interferon or poly(I) X poly(C)

Journal of Interferon Research
|January 1, 1983
PubMed

Insights

Interferon (IFN) treatment enhances key enzyme activities in mouse tissues and IFN-sensitive leukemia cells, but not IFN-resistant cells. Tumor presence did not alter the host

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • Interferons (IFNs) are crucial signaling proteins in the immune system.
  • IFN-mediated enzyme activities, including protein kinase and 2-5A synthetase, are key to IFN's biological effects.
  • Understanding IFN action in different tissues and tumor cells is vital for therapeutic applications.

Purpose of the Study:

  • To investigate the action of interferon (IFN) on mouse tissues and L-1210 leukemia cells.
  • To assess the impact of IFN on IFN-sensitive (L-1210S) and IFN-resistant (L-1210R) leukemia cells.
  • To evaluate the role of IFN-induced enzymes, p67K kinase and 2-5A synthetase, in response to IFN treatment.

Main Methods:

  • Measuring protein kinase and 2-5A synthetase activities in various mouse tissues and L-1210 leukemia cells.
  • Administering IFN or poly(I) X poly(C) (an IFN inducer) to control and tumor-bearing mice.
  • Analyzing enzyme activity in lung, spleen, and leukemia cells (L-1210S and L-1210R).

Main Results:

  • IFN treatment and poly(I) X poly(C) administration enhanced 2-5A synthetase and p67K kinase in mouse lung and spleen.
  • These enzyme activities were significantly increased in IFN-sensitive L-1210S leukemia cells.
  • No significant changes in enzyme activities were observed in IFN-resistant L-1210R leukemia cells.

Conclusions:

  • The presence of tumor cells did not modify the host's response to IFN treatment.
  • Biochemical evidence demonstrates differential responses of IFN-sensitive and IFN-resistant tumor cells to host IFN therapy.
  • These findings highlight the importance of cellular sensitivity in determining the efficacy of IFN-based treatments.

Related Concept Videos